People of the Injury Prevention Center


Psychiatry Faculty Bonar

Erin Bonar, PhD


Sexual Violence Content Lead, Research Core, University of Michigan Injury Prevention Center

Assistant Professor, Psychiatry, U-M Medical School

Director of Clinical Programs, Addiction Treatment Services, University of Michigan

Adjunct Assistant Professor, Psychology, University of Michigan College of Literature, Science, and the Arts

Email: erinbona@umich.edu Sites: https://medicine.umich.edu/dept/psychiatry/erin-e-bonar-phd https://www.edx.org/course/injury-prevention-for-children-teens

Biography

Dr. Bonar is a licensed clinical psychologist and an Assistant Professor in the Department of Psychiatry where she is also Director of Clinical Programs for the U-M Addiction Treatment Services. She is the Sexual Violence Content Lead for the U-M Injury Prevention Center. Dr. Bonar’s research focuses on preventing negative outcomes associated with substance use among emerging adults (as well as adolescents and adults), including consequences such as sexual violence, injury, overdose, and transmission of HIV/STIs. Dr. Bonar also contributed to the 8-module Child and Adolescent Injury Prevention on edX in the Dating and Sexual Violence section.

Research Interests

Dr. Bonar investigates the links between substance use, risky behaviors, and negative health and social outcomes in vulnerable populations with special attention to the role of social cognitive factors. She is interested in developing and adapting interventions augmented by mHealth for prevention and treatment of substance use and related conditions. Specifically, she is interested in:
• Optimizing substance use interventions across community settings, including health care settings and tertiary substance use disorder treatment, particularly among emerging adults.
• Understanding and reducing substance use and concomitant risk behaviors (e.g., sexual/HIV, impaired driving, prescription opioid overdose), and related negative consequences (sexual assault, injury) among underserved populations.
• Employing technologies in the prevention and treatment of substance use to increase scalability and public health impact.